Novopyxis

OverviewSuggest Edit

Novopyxis is a biotechnology company using mathematics and machine learning to engineer medical technology. Its flagship drug is both cardioprotective and neuroprotective, and can be used for the treatment of cardiomyopathy. The company also develops a device for medical dermatology applications.
TypePrivate
Founded2013
Websitenovopyxis.com

Latest Updates

Employees (est.) (Nov 2020)5
Cybersecurity ratingBMore

Novopyxis Financials and Metrics

Summary Metrics

Founding Date

2013

Novopyxis total Funding

$855.9 k

Novopyxis latest funding size

$512.90 k

Time since last funding

3 years ago

Novopyxis investors

Novopyxis's latest funding round in July 2017 was reported to be $512.9 k. In total, Novopyxis has raised $855.9 k
Show all financial metrics

Novopyxis Cybersecurity Score

Cybersecurity ratingPremium dataset

B

85/100

SecurityScorecard logo

Novopyxis Online and Social Media Presence

Embed Graph

Novopyxis Frequently Asked Questions

  • When was Novopyxis founded?

    Novopyxis was founded in 2013.

  • How many employees does Novopyxis have?

    Novopyxis has 5 employees.

  • Who are Novopyxis competitors?

    Competitors of Novopyxis include CIS Pharma, SurModics and Aquavit Pharmaceuticals.